These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 35081898)

  • 21. Liraglutide attenuates renal tubular ectopic lipid deposition in rats with diabetic nephropathy by inhibiting lipid synthesis and promoting lipolysis.
    Su K; Yi B; Yao BQ; Xia T; Yang YF; Zhang ZH; Chen C
    Pharmacol Res; 2020 Jun; 156():104778. PubMed ID: 32247822
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of type 2 diabetic mellitus animal models via interactions between insulin and mitogen‑activated protein kinase signaling pathways induced by a high fat and sugar diet and streptozotocin.
    Zhuo J; Zeng Q; Cai D; Zeng X; Chen Y; Gan H; Huang X; Yao N; Huang D; Zhang C
    Mol Med Rep; 2018 Apr; 17(4):5132-5142. PubMed ID: 29393432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of Insig-1 protects β cell against glucolipotoxicity via SREBP-1c.
    Chen K; Jin P; He HH; Xie YH; Xie XY; Mo ZH
    J Biomed Sci; 2011 Aug; 18(1):57. PubMed ID: 21843373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Mechanism study of the protective effects of selective cyclooxygenase-2 enzyme inhibitors on the liver of rats with type 2 diabetes mellitus combined with nonalcoholic steatohepatitis via Rho/ROCK pathway].
    Yuan L; Tian F
    Zhonghua Gan Zang Bing Za Zhi; 2022 Jan; 30(1):74-80. PubMed ID: 35152673
    [No Abstract]   [Full Text] [Related]  

  • 25. Protective effect of liraglutide on the myocardium of type 2 diabetic rats by inhibiting polyadenosine diphosphate-ribose polymerase-1.
    Xue DD; Zhang X; Li DW; Yang YL; Liu JJ
    World J Diabetes; 2023 Feb; 14(2):110-119. PubMed ID: 36926657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term liraglutide treatment is associated with increased insulin content and secretion in β-cells, and a loss of α-cells in ZDF rats.
    Schwasinger-Schmidt T; Robbins DC; Williams SJ; Novikova L; Stehno-Bittel L
    Pharmacol Res; 2013 Oct; 76():58-66. PubMed ID: 23891763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metformin, sitagliptin, and liraglutide modulate serum retinol-binding protein-4 level and adipocytokine production in type 2 diabetes mellitus rat model.
    Abbas NAT; El Salem A
    Can J Physiol Pharmacol; 2018 Dec; 96(12):1226-1231. PubMed ID: 30075088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liraglutide, Sitagliptin, and Insulin Glargine Added to Metformin: The Effect on Body Weight and Intrahepatic Lipid in Patients With Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease.
    Yan J; Yao B; Kuang H; Yang X; Huang Q; Hong T; Li Y; Dou J; Yang W; Qin G; Yuan H; Xiao X; Luo S; Shan Z; Deng H; Tan Y; Xu F; Xu W; Zeng L; Kang Z; Weng J
    Hepatology; 2019 Jun; 69(6):2414-2426. PubMed ID: 30341767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of zhenqing recipe on non-alcoholic fatty liver in type 2 diabetes rats and the expression of SIK1].
    Zheng H; Hong SC; Yu J; Wen XY
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Jul; 34(7):846-52. PubMed ID: 25137852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin enhances the biogenesis of nuclear sterol regulatory element-binding protein (SREBP)-1c by posttranscriptional down-regulation of Insig-2A and its dissociation from SREBP cleavage-activating protein (SCAP).SREBP-1c complex.
    Yellaturu CR; Deng X; Park EA; Raghow R; Elam MB
    J Biol Chem; 2009 Nov; 284(46):31726-34. PubMed ID: 19759400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liraglutide combined with human umbilical cord mesenchymal stem cell transplantation inhibits beta-cell apoptosis via mediating the ASK1/JNK/BAX pathway in rats with type 2 diabetes.
    Wang W; Wu RD; Chen P; Xu XJ; Shi XZ; Huang LH; Shao ZL; Guo W
    Diabetes Metab Res Rev; 2020 Feb; 36(2):e3212. PubMed ID: 31411368
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liraglutide improves hepatic insulin resistance via the canonical Wnt signaling pathway.
    Qin Y; Chen M; Yang Y; Zhou XR; Shao SY; Wang DW; Yuan G
    Mol Med Rep; 2018 May; 17(5):7372-7380. PubMed ID: 29568881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of liraglutide in treating type 2 diabetes mellitus complicated with non-alcoholic fatty liver disease.
    Tian F; Zheng Z; Zhang D; He S; Shen J
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30473540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigallocatechin-3-gallate ameliorates glucolipid metabolism and oxidative stress in type 2 diabetic rats.
    Li W; Zhu C; Liu T; Zhang W; Liu X; Li P; Zhu T
    Diab Vasc Dis Res; 2020; 17(6):1479164120966998. PubMed ID: 33280417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Celecoxib ameliorates non-alcoholic steatohepatitis in type 2 diabetic rats via suppression of the non-canonical Wnt signaling pathway expression.
    Tian F; Zhang YJ; Li Y; Xie Y
    PLoS One; 2014; 9(1):e83819. PubMed ID: 24404139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glucagon Like Peptide-1 Receptor Agonists Alter Pancreatic and Hepatic Histology and Regulation of Endoplasmic Reticulum Stress in High-fat Diet Mouse Model.
    Fang T; Huang S; Chen Y; Chen Z; Chen J; Hu W
    Exp Clin Endocrinol Diabetes; 2021 Sep; 129(9):625-633. PubMed ID: 32961563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effects of electroacupuncture combined with dietary control on liver endoplasmic reticulum stress in rats with non-alcoholic fatty liver disease].
    Zhang Y; Tang C; Tian Y; Yuan H; Gao R; Cao J
    Zhongguo Zhen Jiu; 2016 Sep; 36(9):951-956. PubMed ID: 29231390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liraglutide improves lipid metabolism by enhancing cholesterol efflux associated with ABCA1 and ERK1/2 pathway.
    Wu YR; Shi XY; Ma CY; Zhang Y; Xu RX; Li JJ
    Cardiovasc Diabetol; 2019 Nov; 18(1):146. PubMed ID: 31706303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The HIF-2α/PPARα pathway is essential for liraglutide-alleviated, lipid-induced hepatic steatosis.
    Wang H; Wang L; Li Y; Luo S; Ye J; Lu Z; Li X; Lu H
    Biomed Pharmacother; 2021 Aug; 140():111778. PubMed ID: 34062416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endoplasmic reticulum stress is involved in hepatic SREBP-1c activation and lipid accumulation in fructose-fed mice.
    Zhang C; Chen X; Zhu RM; Zhang Y; Yu T; Wang H; Zhao H; Zhao M; Ji YL; Chen YH; Meng XH; Wei W; Xu DX
    Toxicol Lett; 2012 Aug; 212(3):229-40. PubMed ID: 22698815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.